<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We present a 12-year-old girl with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> and associated <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> who developed an unusual manifestation of <z:hpo ids='HP_0000979'>purpura</z:hpo> fulminans in an accelerated fashion </plain></SENT>
<SENT sid="1" pm="."><plain>The patient improved after prompt treatment with <z:chebi fb="2" ids="50249">anticoagulants</z:chebi>, aggressive immunosuppressive drugs and plasmapheresis </plain></SENT>
<SENT sid="2" pm="."><plain>This is the first pediatric case of <z:hpo ids='HP_0000979'>purpura</z:hpo> fulminans due to <z:e sem="disease" ids="C0409983" disease_type="Disease or Syndrome" abbrv="">secondary antiphospholipid syndrome</z:e> of <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We suggest that SLE patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> should be followed closely for similar complications </plain></SENT>
</text></document>